Northwest Biotherapeutics, Inc. (NWBO)
OQB · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Northwest Biotherapeutics, Inc., a biotechnology company, engages in the development of personalized immune therapies for cancer. The company develops DCVax, a platform technology which uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It also engages in the development of its lead product candidate DCVax-L in Phase III trials for glioblastoma multiforme brain cancer. In addition, the company develops DCVax-Direct in Phase I trials to treat inoperable solid tumors. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.
Peers in Healthcare
Northwest Biotherapeutics, Inc. has no peer companies in this window.
Recent press releases
Northwest Biotherapeutics, Inc. has not issued a press release in this window.
SEC filings
All filings →Northwest Biotherapeutics, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Northwest Biotherapeutics, Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Northwest Biotherapeutics, Inc.
All people →No officers or directors have been indexed for Northwest Biotherapeutics, Inc..